New biomarker discoveries are driving developments in diagnostics and helping to identify patients most likely to benefit from available treatments. In assessing emerging developments, Biopharm Reports researches the latest findings with diagnostic utility in areas of unmet need. These include commercial developments, the prediction or early detection of disease, new opportunities to develop non-invasive or minimally invasive tests, patient stratification and other areas.
Copyright BioPharm Reports 2011 l All Rights Reserved
